Your browser doesn't support javascript.
loading
Rapid exome sequencing in critically ill infants: implementation in routine care from French regional hospital's perspective.
Wells, Constance F; Boursier, Guilaine; Yauy, Kevin; Ruiz-Pallares, Nathalie; Mechin, Déborah; Ruault, Valentin; Tharreau, Mylène; Blanchet, Patricia; Pinson, Lucile; Coubes, Christine; Fila, Marc; Baleine, Julien; Pidoux, Odile; Badr, Maliha; Milesi, Christophe; Cambonie, Gilles; Mesnage, Renaud; Dereure, Maëlle; Ardouin, Olivier; Guignard, Thomas; Geneviève, David; Barat-Houari, Mouna; Willems, Marjolaine.
Afiliação
  • Wells CF; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Boursier G; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Yauy K; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Ruiz-Pallares N; Institute of Advanced Biosciences, Centre de recherche UGA, Inserm U 1209, CNRS UMR 5309, Grenoble, France.
  • Mechin D; SeqOne Genomics, Montpellier, France.
  • Ruault V; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Tharreau M; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Blanchet P; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Pinson L; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Coubes C; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Fila M; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Baleine J; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
  • Pidoux O; Pediatric Nephrology department, Montpellier university hospital, Univ, Montpellier, France.
  • Badr M; Department of Neonatal Medicine and Pediatric Intensive Care, Montpellier university Hospital, Univ, Montpellier, France.
  • Milesi C; Department of Neonatal Medicine and Pediatric Intensive Care, Montpellier university Hospital, Univ, Montpellier, France.
  • Cambonie G; Department of Neonatal Medicine and Pediatric Intensive Care, Montpellier university Hospital, Univ, Montpellier, France.
  • Mesnage R; Department of Neonatal Medicine and Pediatric Intensive Care, Montpellier university Hospital, Univ, Montpellier, France.
  • Dereure M; Department of Neonatal Medicine and Pediatric Intensive Care, Montpellier university Hospital, Univ, Montpellier, France.
  • Ardouin O; Department of Neonatal Medicine and Pediatric Intensive Care, Montpellier university Hospital, Univ, Montpellier, France.
  • Guignard T; Clinical research and epidemiology department, Montpellier university hospital, Univ, Montpellier, France.
  • Geneviève D; Molecular medicine and genomics platform, Montpellier university hospital, Montpellier, France.
  • Barat-Houari M; Unit of Chromosomal Genetics and Research Plateform Chromostem, Montpellier university hospital, Univ, Montpellier, France.
  • Willems M; Department of Medical Genetics, Rare diseases and Personalized medicine, CHU Montpellier, Univ Montpellier, Montpellier, France.
Eur J Hum Genet ; 30(9): 1076-1082, 2022 09.
Article em En | MEDLINE | ID: mdl-35729264
ABSTRACT
This monocentric study included fifteen children under a year old in intensive care with suspected monogenic conditions for rapid trio exome sequencing (rES) between April 2019 and April 2021. The primary outcome was the time from blood sampling to rapid exome sequencing report to parents. All results were available within 16 days and were reported to parents in or under 16 days in 13 of the 15 individuals (86%). Six individuals (40%) received a diagnosis with rES, two had a genetic condition not diagnosed by rES. Eight individuals had their care impacted by their rES results, four were discharged or died before the results. This small-scale study shows that rES can be implemented in a regional University hospital with rapid impactful diagnosis to improve care in critically ill infants.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estado Terminal / Exoma Limite: Adolescent / Child / Humans / Infant Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Estado Terminal / Exoma Limite: Adolescent / Child / Humans / Infant Idioma: En Revista: Eur J Hum Genet Assunto da revista: GENETICA MEDICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França